The industry could see payment, workforce and insurance coverage changes depending on how the Trump administration weighs in ...

Eli Lilly, Bristol Myers Squibb, Sanofi and Novartis are seeking to block a major hospital trade group from intervening in court cases over their proposed 340B drug rebate models.

after the regulator rejected their plans to change how they offer 340B discounts. In December, Sanofi and Bristol Myers Squibb followed suit. The discount program designed to keep safety-net ...

Sanofi has bought back a €3bn ($3.1bn) stake held by cosmetics giant L'Oréal, the first of multiple share buybacks the French drugmaker has planned for 2025. L'Oréal was selling 29,556,650 ...

J&J said its plan to give hospitals rebates instead of upfront discounts on 340B-eligible drugs is necessary to prevent waste and abuse, while hospitals — and the government — maintain the ...